Ország: Egyesült Államok
Nyelv: angol
Forrás: NLM (National Library of Medicine)
SERTRALINE HYDROCHLORIDE (UNII: UTI8907Y6X) (SERTRALINE - UNII:QUC7NX6WMB)
Torrent Pharmaceuticals Limited
SERTRALINE HYDROCHLORIDE
SERTRALINE 25 mg
ORAL
PRESCRIPTION DRUG
Sertraline tablets is indicated for the treatment of the following [See Clinical Studies (14)]: • Major depressive disorder (MDD) • Obsessive-compulsive disorder (OCD) • Panic disorder (PD) • Posttraumatic stress disorder (PTSD) • Social anxiety disorder (SAD) • Premenstrual dysphoric disorder (PMDD) Sertraline tablets is contraindicated in patients: • Taking, or within 14 days of stopping, MAOIs, (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [See Warnings and Precautions (5.2), Drug Interactions (7.1)]. • Taking pimozide [See Drug Interactions (7.1)]. • With known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [See Adverse Reactions (6.1, 6.2)]. Risk Summary Overall, available published epidemiologic studies of pregnant women exposed to sertraline hydrochloride in the first trimester suggest no difference in major birth defect risk compared to the background rate for major birth defects in
Sertraline 25 mg tablets, USP: White to off white, capsule shaped biconvex film coated tablets with "Torrent logo" debossed on one side and "25" debossed with break line separating 2 and 5 on other side. NDC 13668-004-30 Bottles of 30 NDC 13668-004-50 Bottles of 50 NDC 13668-004-90 Bottles of 90 NDC 13668-004-01 Bottles of 100 NDC 13668-004-05 Bottles of 500 NDC 13668-004-10 Bottles of 1000 NDC 13668-004-09 Bottles of 9990 Sertraline 50 mg tablets, USP: White to off white, capsule shaped biconvex film coated tablets with "Torrent logo" debossed on one side and "50MG" debossed with break line separating 50 and MG on other side. NDC 13668-005-30 Bottles of 30 NDC 13668-005-50 Bottles of 50 NDC 13668-005-90 Bottles of 90 NDC 13668-005-01 Bottles of 100 NDC 13668-005-05 Bottles of 500 NDC 13668-005-10 Bottles of 1000 NDC 13668-005-58 Bottles of 4500 Sertraline 100 mg tablets, USP: White to off white, capsule shaped biconvex film coated tablets with "Torrent logo" debossed on one side and "100MG" debossed with break line separating 100 and MG on other side. NDC 13668-006-30 Bottles of 30 NDC 13668-006-50 Bottles of 50 NDC 13668-006-90 Bottles of 90 NDC 13668-006-01 Bottles of 100 NDC 13668-006-05 Bottles of 500 NDC 13668-006-10 Bottles of 1000 NDC 13668-006-13 Bottles of 1300 NDC 13668-006-34 Bottles of 2200 NDC 13668-006-74 100 Unit dose Tablets Store sertraline tablets, USP at 20° to 25° C (68° to 77° F); excursions permitted to 15° to 30° C (59° to 86° F) [See USP Controlled Room Temperature].
Abbreviated New Drug Application
SERTRALINE HYDROCHLORIDE- SERTRALINE HYDROCHLORIDE TABLET, FILM COATED Torrent Pharmaceuticals Limited ---------- MEDICATION GUIDE SERTRALINE (SER tra leen) TABLETS, USP What is the most important information I should know about sertraline tablets? Sertraline tablets and other antidepressant medicines may cause serious side effects. Call your healthcare provider right away if you have any of the following symptoms, or call 911 if there is an emergency. 1. Suicidal thoughts or actions: • Sertraline tablets and other antidepressant medicines may increase suicidal thoughts or actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. • Depression or other serious mental illnesses are the most important causes of suicidal thoughts or actions. • Watch for these changes and call your healthcare provider right away if you notice new or sudden changes in mood, behavior, actions, thoughts, or feelings, especially if severe. o Pay particular attention to such changes when sertraline tablets is started or when the dose is changed. o Keep all follow-up visits with your healthcare provider and call between visits if you are worried about symptoms. Call your healthcare provider right away if you have any of the following symptoms, or call 911 if an emergency, especially if they are new, worse, or worry you: o attempts to commit suicide o acting on dangerous impulses o acting aggressive or violent o thoughts about suicide or dying o new or worse depression o new or worse anxiety or panic attacks o feeling agitated, restless, angry or irritable o trouble sleeping o an increase in activity or talking more o other unusual changes in behavior than what is normal for you or mood 2. Serotonin Syndrome. This condition can be life-threatening and symptoms may include: • agitation, hallucinations, coma, or other • nausea, vomiting, or diarrhea changes in mental status • racing heartbeat, high or low blood pressure • sweating or fever • coordination Olvassa el a teljes dokumentumot
SERTRALINE HYDROCHLORIDE- SERTRALINE HYDROCHLORIDE TABLET, FILM COATED TORRENT PHARMACEUTICALS LIMITED ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE SERTRALINE TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR SERTRALINE TABLETS. SERTRALINE TABLETS, FOR ORAL USE INITIAL U.S. APPROVAL: 1991 WARNING: SUICIDAL THOUGHTS AND BEHAVIORS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING_ • ANTIDEPRESSANTS INCREASED THE RISK OF SUICIDAL THOUGHTS AND BEHAVIORS IN PEDIATRIC AND YOUNG ADULT PATIENTS (5.1) • CLOSELY MONITOR FOR CLINICAL WORSENING AND EMERGENCE OF SUICIDAL THOUGHTS AND BEHAVIORS (5.1) RECENT MAJOR CHANGES Warning and Precautions, QTc Prolongation (5.10) 12/2017 INDICATIONS AND USAGE Sertraline tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of (1): (1) • Major depressive disorder (MDD) (1) • Obsessive-compulsive disorder (OCD) (1) • Panic disorder (PD) (1) • Post-traumatic stress disorder (PTSD) (1) • Social anxiety disorder (SAD) (1) • Premenstrual dysphoric disorder (PMDD) (1) DOSAGE AND ADMINISTRATION • If inadequate response to starting dosage, titrate in 25 to 50 mg per day increments once weekly in MDD, OCD, PD, PTSD, and SAD (2.1) (2) • See Full Prescribing Information for titration in PMDD (2.2) (2) • Hepatic impairment: (2) o Mild: Recommended starting and maximum dosage is half (2) recommended dosage (2.4) (2) o Moderate or severe: Not recommended (2.4) (2) When discontinuing sertraline tablets, reduce dose gradually (2.6, 5.4) (2) INDICATION STARTING DOSAGE MAXIMUM DOSAGE MDD (2.1) 50 mg per day 200 mg per day OCD (2.1) 25 mg per day (ages 6 to12) 50 mg per day (ages ≥ 13) 200 mg per day PD,PTSD,SAD(2.1) 25 mg per day 200 mg per day PMDD (2.2) continuous dosing 50 mg per day 150 mg per day PMDD (2.2) intermittent dosing 50 mg per day during luteal phase only 100 mg per day during luteal phase only DOSAGE FORMS AND STRENGTHS Tablets: 25 mg, Olvassa el a teljes dokumentumot